%0 Journal Article
%T Bone turnover rate and bone formation/resorption balance during the early stage after switching from a bone resorption inhibitor to denosumab are predictive factors of bone mineral density change
%A Shinichi Nakatoh
%J Archive of "Osteoporosis and Sarcopenia".
%D 2017
%R 10.1016/j.afos.2016.12.001
%X This study aimed to investigate the correlation between bone mineral density (BMD) and the turnover rate [¡Ì(MoMf2 + MoMr2), multiple of median formation (MoMf) was calculated as bone-specific alkaline phosphatase (BAP) value/18.6 and multiple of median resorption (MoMr) as tartrate-resistant acid phosphatase 5b (TRACP-5b) value/463] and the balance (MoMf/MoMr) and to compare differences in therapeutic effects evoked by differences in previous treatments
%K Osteoporosis
%K Denosumab
%K Bone mineral density
%K Bone-specific alkaline phosphatase
%K Tartrate-resistant acid phosphatase 5b
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372821/